Satsuma Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview

Satsuma Pharmaceuticals

06/08/2021 16:51

* Satsuma Pharmaceuticals Inc  STSA.OQ   STSA.O  is expected
to show a no change in quarterly revenue when it reports
results on August 10 (estimated). 
​* Refinitiv's mean analyst estimate for Satsuma Pharmaceuticals
Inc is for a loss of 41 cents per share. For the same quarter
last year, the company reported a loss of 65 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $15​, about 65.9% above​ its last closing
price of $5.11. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.41       -0.42      -0.48     Missed  -15.2
 Dec. 31 2020  -0.65       -0.53      -0.72     Missed  -36.2
 Sep. 30 2020  -0.75       -0.69      -0.69     Met     0.7​
 Jun. 30 2020  -0.71       -0.71      -0.65     Beat    8.9
 Mar.          -0.67​      -0.67      -0.68     Missed  -1.5​
 31​ 2020​                                              
 Dec. 31 2019  -0.80       -0.80      -0.62     Beat    23​
 Sep. 30 2019  -1.01       -1.01      -2.26     Missed  -123.8
 This summary was machine generated August 6 at 15:51 GMT.  All
figures in US dollars unless otherwise stated